Table 1.
Country | Population status | Prevalence (no. pos/total) | Detection method | Subtype(s) (n) | Mixed ST’s detected? | References |
---|---|---|---|---|---|---|
Brazil | Captive | 13 (10/79) | CM | – | – | [43] |
Brazil | Captive | 77 (30/39) | PCR, SS | ST1 (3), ST4 (1), ST5 (14), ST8 (1) | No | [44] |
China | Wild | 0 (0/4) | PCR, SS | – | – | [45] |
Iran | Wild | 25 (3/12) | CM | – | – | [46] |
Iran | Wild | 44 (11/25) | CM | – | – | [47] |
Italy | Wild | 62 (26/42) | PCR, SS, NGS | ST3(1), ST5 (10), ST15 (21) | Yes | [48] |
Poland | Wild | 50 (1/2) | PCR, SS | ST5 (1) | No | [49] |
Poland | Captive | 80 (8/10) | PCR, SS | ST5 (8) | No | [50] |
Portugal | Wild | 29 (42/144) | PCR, SS | ST5 (42) | No | [51] |
Portugal | Wild | 34 (34/99) | PCR, NGS | ST5 (34), ST10a (1), ST13 (1), ST14 (1), ST15 (1), ST24b (1), ST43 (2) | Yes | This study |
Slovakia | Captive | 50 (1/2) | PCR, SS | ST12 (1) | No | [52] |
Slovakia | Wild | ND | PCR, SS | ST15 (4), ST10 (1) | ND | [53] |
South Korea | Wild | 10 (45/433) | PCR, SS | ST5 (45) | No | [54] |
Spain | Wild | 0.7 (1/142) | PCR, SS | ST5 (1) | No | [55] |
Spain | Wild | 10 (36/360) | PCR, NGS | ST5 (22), ST15 (1) | Yes | This study |
UK | Captive | 50 (1/2) | PCR, SS | ST5 (1) | No | [56] |
UK | Captive | 50 (2/4) | PCR, SS | ST5 (2) | No | [57] |
Subtypes previously reported in humans (regardless of their true zoonotic potential) are in bold.
CM: Conventional microscopy, ND: Not determined, NGS: Next-generation sequencing, PCR: Polymerase chain reaction, SS: Sanger sequencing.